Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-001225
Filing Date
2022-01-06
Accepted
2022-01-06 17:06:31
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7376
  Complete submission text file 0000899243-22-001225.txt   8729
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMYLYX PHARMACEUTICALS, INC. 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address
Klee Justin B. (Reporting) CIK: 0001898314 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41199 | Film No.: 22515537